This inventor holds 1 USPTO granted patent. Top assignee: Per Immune Holdings, Inc.. Active years: 1999.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1999
Title: Ebo Bos: Innovator in Cancer Research
Introduction
Ebo Bos is a notable inventor based in Oss, Netherlands. He has made significant contributions to the field of cancer research through his innovative work on tumor-associated epitopes. His research focuses on the development of diagnostic and therapeutic tools for human cancers.
Latest Patents
Ebo Bos holds a patent for a tumor-associated epitope. This invention relates to the epitopes to which monoclonal antibody 88BV59 and antibody 16.88 react. These antibodies were produced by B-cell lines derived from B-cells of cancer patients who were actively immunized with autologous tumor antigens. Both epitopes are found on the same antigen in tumor tissue. These epitopes can be utilized in both diagnostic procedures and therapy for human cancers. He has 1 patent to his name.
Career Highlights
Ebo Bos is associated with Per Immune Holdings, Inc., where he continues to advance his research in cancer immunology. His work has the potential to significantly impact the way cancers are diagnosed and treated.
Collaborations
Ebo collaborates with notable colleagues, including Sandra M. Butler and Nicholas Pomato. Their combined expertise enhances the research efforts at Per Immune Holdings, Inc.
Conclusion
Ebo Bos is a dedicated inventor whose work in cancer research is paving the way for innovative diagnostic and therapeutic solutions. His contributions are vital in the ongoing fight against cancer.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile